A large pharmaceutical manufacturer ranked within the top 20, recognizes that the increasing approval of therapies in recent years poses a challenge. Shifting away from their established standard-of-care therapy may result in a reduction in the utilization of their brand.
Would you like to learn more about our approach to predicting drivers of patient switching patterns?
